| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Will the current GEOVAX LABS volatility rise frighten investors?
 | By Raphi Shpitalnik | Macroaxis Story |
It appears GEOVAX LABS will continue to recover much faster as its share price surged up 62.42% today. The firm current daily volatility is 14.16 percent, with a beta of -1.86 and an alpha of 0.99 over DOW. As many baby boomers are still indifferent towards business services, it makes sense to break down GEOVAX LABS INC. We will look into some reasons why it is still possible for GEOVAX LABS to maintain above-average margins while minimizing volatility.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
GEOVAX LABS INC currently holds roughly 11.58 M in cash with (1.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.25. GEOVAX LABS INC currently holds 201.09 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest GEOVAX LABS is not taking enough advantage from borrowing. The entity has a current ratio of 12.45, suggesting that it is liquid enough and is able to pay its financial obligations when due.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as GeoVax Labs. Your research has to be compared to or analyzed against GeoVax Labs' peers to derive any actionable benefits. When done correctly, GeoVax Labs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in GeoVax Labs.
Investing in GeoVax Labs, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding GeoVax Labs along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GeoVax Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
How important is GeoVax Labs's Liquidity
GeoVax Labs financial leverage refers to using borrowed capital as a funding source to finance GeoVax Labs ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. GeoVax Labs financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to GeoVax Labs' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of GeoVax Labs' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between GeoVax Labs's total debt and its cash.
GeoVax Labs Gross Profit
GeoVax Labs Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing GeoVax Labs previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show GeoVax Labs Gross Profit growth over the last 10 years. Please check GeoVax Labs' gross profit and other fundamental indicators for more details.
GeoVax Labs Correlation with Peers
Investors in GeoVax can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in GeoVax Labs. Diversification will allow for the same portfolio return with reduced risk. The correlation table of GeoVax Labs and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities GeoVax is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of GeoVax for more details
Another angle On GeoVax Labs
GEOVAX LABS is dangerous given 1 month investment horizon. GEOVAX LABS INC holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had 0.12% of return per unit of volatility over the last month. Our viewpoint regarding determining the risk of a stock is to use both market data as well as company specific technical data. We were able to analyze twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.71% are justified by taking the suggested risk. Use GEOVAX LABS INC market risk adjusted performance of (0.35), and Risk Adjusted Performance of 0.0456 to evaluate company specific risk that cannot be diversified away.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of GeoVax Labs. Please refer to our Terms of Use for any information regarding our disclosure principles.